China · Delayed Price · Currency is CNY Newland Pharmaceutical Statistics
Total Valuation
SHE:301277 has a market cap or net worth of CNY 5.81 billion. The enterprise value is 5.03 billion.
| Market Cap | 5.81B |
| Enterprise Value | 5.03B |
Important Dates
The next estimated earnings date is Tuesday, August 12, 2025.
| Earnings Date | Aug 12, 2025 |
| Ex-Dividend Date | Apr 16, 2025 |
Share Statistics
SHE:301277 has 392.08 million shares outstanding. The number of shares has increased by 1.13% in one year.
| Current Share Class | 392.08M |
| Shares Outstanding | 392.08M |
| Shares Change (YoY) | +1.13% |
| Shares Change (QoQ) | +1.01% |
| Owned by Insiders (%) | 66.24% |
| Owned by Institutions (%) | 1.08% |
| Float | 89.15M |
Valuation Ratios
The trailing PE ratio is 33.43.
| PE Ratio | 33.43 |
| Forward PE | n/a |
| PS Ratio | 7.63 |
| PB Ratio | 3.63 |
| P/TBV Ratio | 3.72 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | 43.34 |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 22.47, with an EV/FCF ratio of -1,445.77.
| EV / Earnings | 28.85 |
| EV / Sales | 6.60 |
| EV / EBITDA | 22.47 |
| EV / EBIT | 27.23 |
| EV / FCF | -1,445.77 |
Financial Position
The company has a current ratio of 6.12, with a Debt / Equity ratio of 0.00.
| Current Ratio | 6.12 |
| Quick Ratio | 5.90 |
| Debt / Equity | 0.00 |
| Debt / EBITDA | 0.02 |
| Debt / FCF | -1.43 |
| Interest Coverage | 979.29 |
Financial Efficiency
Return on equity (ROE) is 11.21% and return on invested capital (ROIC) is 7.41%.
| Return on Equity (ROE) | 11.21% |
| Return on Assets (ROA) | 6.46% |
| Return on Invested Capital (ROIC) | 7.41% |
| Return on Capital Employed (ROCE) | 11.14% |
| Revenue Per Employee | 730,943 |
| Profits Per Employee | 167,258 |
| Employee Count | 1,042 |
| Asset Turnover | 0.43 |
| Inventory Turnover | 14.18 |
Taxes
In the past 12 months, SHE:301277 has paid 27.65 million in taxes.
| Income Tax | 27.65M |
| Effective Tax Rate | 13.70% |
Stock Price Statistics
The stock price has increased by +62.54% in the last 52 weeks. The beta is 0.48, so SHE:301277's price volatility has been lower than the market average.
| Beta (5Y) | 0.48 |
| 52-Week Price Change | +62.54% |
| 50-Day Moving Average | 14.65 |
| 200-Day Moving Average | 11.77 |
| Relative Strength Index (RSI) | 51.84 |
| Average Volume (20 Days) | 12,040,970 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, SHE:301277 had revenue of CNY 761.64 million and earned 174.28 million in profits. Earnings per share was 0.44.
| Revenue | 761.64M |
| Gross Profit | 295.37M |
| Operating Income | 184.67M |
| Pretax Income | 201.79M |
| Net Income | 174.28M |
| EBITDA | 221.32M |
| EBIT | 184.67M |
| Earnings Per Share (EPS) | 0.44 |
Balance Sheet
The company has 787.53 million in cash and 4.99 million in debt, giving a net cash position of 782.55 million or 2.00 per share.
| Cash & Cash Equivalents | 787.53M |
| Total Debt | 4.99M |
| Net Cash | 782.55M |
| Net Cash Per Share | 2.00 |
| Equity (Book Value) | 1.60B |
| Book Value Per Share | 4.08 |
| Working Capital | 965.72M |
Cash Flow
In the last 12 months, operating cash flow was 134.08 million and capital expenditures -137.56 million, giving a free cash flow of -3.48 million.
| Operating Cash Flow | 134.08M |
| Capital Expenditures | -137.56M |
| Free Cash Flow | -3.48M |
| FCF Per Share | -0.01 |
Margins
Gross margin is 38.78%, with operating and profit margins of 24.25% and 22.88%.
| Gross Margin | 38.78% |
| Operating Margin | 24.25% |
| Pretax Margin | 26.49% |
| Profit Margin | 22.88% |
| EBITDA Margin | 29.06% |
| EBIT Margin | 24.25% |
| FCF Margin | n/a |
Dividends & Yields
This stock pays an annual dividend of 0.29, which amounts to a dividend yield of 1.93%.
| Dividend Per Share | 0.29 |
| Dividend Yield | 1.93% |
| Dividend Growth (YoY) | 40.00% |
| Years of Dividend Growth | 2 |
| Payout Ratio | 45.91% |
| Buyback Yield | -1.13% |
| Shareholder Yield | 0.80% |
| Earnings Yield | 3.00% |
| FCF Yield | -0.06% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Stock Splits
The last stock split was on April 16, 2025. It was a forward split with a ratio of 1.4.
| Last Split Date | Apr 16, 2025 |
| Split Type | Forward |
| Split Ratio | 1.4 |
Scores
SHE:301277 has an Altman Z-Score of 11.51 and a Piotroski F-Score of 4.
| Altman Z-Score | 11.51 |
| Piotroski F-Score | 4 |